Injection techniques: a guide for nursing students

Injections are one of the most fundamental clinical skills in nursing. Three routes — intramuscular (IM), subcutaneous (SQ), and intradermal (ID) — each require a different technique, a different needle, and a different anatomical site. Choosing the wrong route, wrong gauge, or wrong angle can cause tissue damage, medication failure, or patient harm. This guide covers everything you need to administer injections safely: site selection, needle selection, angle and volume, the Z-track method, the aspiration debate, site rotation, sharps safety, and the NCLEX-tested scenarios that trip up students the most.

Quick-reference by route:

• IM: 90° angle, 22–25 G, 1–1.5 inch needle, up to 5 mL depending on site
• SQ: 45–90° angle, 25–31 G, 5/8 inch needle, ≤1 mL
• ID: 10–15° angle, 26–27 G, 3/8–5/8 inch needle, 0.01–0.1 mL — visible bleb required

Route comparison: IM vs SQ vs intradermal

Intramuscular injections

Intramuscular injections deliver medication directly into muscle tissue, where the rich blood supply enables faster absorption than the subcutaneous route. Site selection, needle length, and technique all affect how reliably the drug reaches systemic circulation — and how safely it does so.

IM injection sites

Four sites are used clinically. Each has different landmarks, volume limits, and risk profiles. The dorsogluteal site remains NCLEX-tested despite being largely abandoned in practice because of sciatic nerve risk.

Needle gauge and length selection

Getting needle length right matters as much as site selection. Too short a needle means medication deposits in subcutaneous tissue instead of muscle — causing altered absorption, local irritation, and, for certain drugs, tissue necrosis.

Step-by-step IM injection technique

1. Verify the medication using the five rights of medication administration — right drug, right dose, right route, right patient, right time.
2. Perform hand hygiene per facility protocol. See the infection control guidelines for the full handwashing sequence.
3. Draw up the medication. Pull back the plunger to the dose volume. For Z-track medications, load without switching needles (use a fresh needle only if contamination occurred during draw-up).
4. Select the site, expose it fully, and put on clean gloves.
5. Cleanse the site with an alcohol swab using a circular outward motion. Allow to dry completely (at least 30 seconds). Wet alcohol stings and can cause local tissue irritation.
6. Stabilize the skin. For Z-track (see below): pull skin 1–1.5 inches laterally. For standard technique in adults: hold skin taut. For pediatric or thin patients: bunch tissue slightly.
7. Insert the needle at 90° with a smooth, dart-like motion. Do not hesitate.
8. Aspiration: per current ACIP and CDC evidence-based guidelines, aspiration before IM injection is not required at the deltoid or ventrogluteal sites because large blood vessels are not present at these locations. If using the dorsogluteal site (where vascular proximity is higher), some clinicians still aspirate — pull back the plunger for 5–10 seconds; if blood appears, withdraw, discard, and start again. Note: older textbooks and some NCLEX questions still indicate aspiration is required for all IM injections. Read the question context carefully — if the question specifies following “traditional technique,” aspiration may be the expected answer.
9. Inject medication slowly and steadily — approximately 1 mL every 10 seconds for comfort.
10. For Z-track: hold for 10 seconds after injecting to allow the medication to disperse before withdrawing.
11. Withdraw the needle at the same angle as insertion in one smooth motion.
12. Release Z-track skin after the needle is fully out.
13. Apply gentle pressure with a dry gauze pad. Do not massage (unless the drug requires it — most IM sites do not).
14. Activate the needle safety device immediately. Dispose in a sharps container — never recap with both hands. Full sharps handling guidelines are covered in the safe medication administration article.
15. Remove gloves, perform hand hygiene, document.

The Z-track technique

The Z-track method is a specific variation of IM injection used to prevent medication from tracking back through the needle path into subcutaneous tissue. When medication seeps back along the track, it can cause pain, skin staining, and tissue necrosis — particularly with iron preparations.

How it works: Pulling the skin laterally before injection displaces the skin and subcutaneous layers relative to the underlying muscle. When the needle is withdrawn and the skin is released, the tissue layers realign — sealing the needle track and trapping the medication in the muscle.

Step by step:

1. Draw up medication as usual.
2. Use the non-dominant hand to pull the skin and subcutaneous tissue 1–1.5 inches (2.5–3.8 cm) laterally away from the injection site.
3. Hold the skin taut throughout the entire injection.
4. Insert the needle at 90° and inject the medication slowly.
5. Hold for 10 seconds with the needle in place before withdrawing — this allows the drug to disperse within the muscle.
6. Withdraw the needle at 90°.
7. Release the skin immediately after needle removal.
8. Do not massage the site.

Drugs requiring Z-track technique:

• Iron dextran (INFeD) — the classic NCLEX example; skin staining and tissue damage are well-documented without Z-track
• Hydroxyzine (Vistaril) — causes significant irritation with subcutaneous contact
• Haloperidol decanoate (Haldol Decanoate) — long-acting oily depot injection
• Diphtheria toxoid
• Any medication the manufacturer specifies must be given via Z-track

Z-track is now considered best practice for all IM injections by many professional nursing organizations — not just for the drugs listed above.

Subcutaneous injections

Subcutaneous injections deposit medication into the layer of fat and connective tissue beneath the skin but above the muscle. This route produces slower, more sustained absorption than IM, which is ideal for drugs like insulin and heparin that require predictable, prolonged effects.

SQ injection sites and absorption

The abdomen offers the fastest and most consistent absorption because of its rich blood supply and ease of access for self-injection. Avoid the 2-inch zone surrounding the navel — the umbilical region has denser fibrous tissue that slows absorption and increases discomfort.

The outer thighs and upper outer arms are acceptable alternative sites. The upper back (scapular region) can be used by healthcare providers but is inaccessible for self-injection.

SQ needle selection

Use 25–31 gauge needles, 5/8 inch (16 mm) in length for most adults. For very thin or cachectic patients, a ½ inch (12 mm) needle is appropriate. Insulin syringes use short needles (4–8 mm) designed for the subcutaneous layer.

Angle of insertion

• 45°: Use for thin patients with minimal subcutaneous adipose tissue, or when using a ½ inch needle
• 90°: Standard angle for most adults when using a 5/8 inch needle and adequate subcutaneous tissue is present

The pinch technique — lifting a fold of skin and subcutaneous tissue between the thumb and forefinger before insertion — is used to ensure subcutaneous, not muscle, placement. Use it for thinner patients or shorter needle lengths. With a 5/8 inch needle in patients with normal adipose tissue, the pinch technique is optional.

SQ volume limits

The subcutaneous space does not accommodate large volumes. Limit each SQ injection to ≤1 mL. Some sources allow up to 1.5 mL in larger patients with generous subcutaneous tissue. Never exceed this — larger volumes cause pain, tissue distension, and erratic absorption.

Common subcutaneous medications

Insulin: Rotate sites within a single anatomical region — for example, use the abdomen consistently rather than switching between abdomen, thigh, and arm. Rotating within a region maintains predictable absorption. Rotating randomly between regions causes significant variability in glucose control. See the insulin administration guide for full site rotation protocols and pen injection technique.

Heparin: After injecting heparin subcutaneously, do not massage the site. Massage disperses the heparin rapidly and unevenly, causing bruising, hematoma formation, and unpredictable anticoagulant effect. Apply gentle pressure with a dry gauze pad only.

Enoxaparin (Lovenox): Prefilled syringes often contain a small air bubble (approximately 0.1 mL). Do not expel this bubble before injection — it is intentional. The air bubble follows the drug into the tissue and helps seal it within the subcutaneous space, reducing leakage and bruising at the insertion site. This applies only to prefilled syringes from the manufacturer. If drawing up enoxaparin from a vial, no air bubble should be present.

Vaccines via SQ route: MMR, varicella, and certain influenza vaccines are given subcutaneously in the outer upper arm or anterolateral thigh. Per ACIP guidelines, aspiration is not required for vaccines given via the SQ route.

SQ injection step by step

1. Verify the medication via the five rights.
2. Perform hand hygiene. Don clean gloves.
3. Draw up the correct dose. For enoxaparin prefilled syringes, do not expel the air bubble.
4. Select the site. For insulin, use the same anatomical region each time and rotate within it.
5. Cleanse with alcohol swab. Allow to dry completely.
6. Pinch the skin (if indicated based on patient size and needle length).
7. Insert the needle at 45° or 90° depending on patient body habitus and needle length.
8. Release the skin pinch (if used) before injecting. Some evidence suggests releasing before injection reduces discomfort.
9. Inject slowly and steadily.
10. Withdraw the needle at the same angle as insertion.
11. Apply gentle pressure with dry gauze. Do not massage (especially for heparin).
12. Activate the needle safety device. Dispose in sharps container immediately.
13. Document site used and rotate for next dose.

Intradermal injections

Intradermal injections deposit a tiny volume of material into the dermis — the layer of skin just below the epidermis. The dermis is poorly vascularized, so absorption is minimal and local. This makes the ID route ideal for diagnostic tests (tuberculin skin test, allergy skin testing) and local anesthetic testing.

ID technique

The defining characteristic of a correctly placed ID injection is a visible bleb or wheal — a pale, raised bump approximately 6–10 mm in diameter that appears as the material stretches the dermis. If no bleb forms, the injection went subcutaneous and the test is invalid.

Site: The volar (inner) surface of the forearm is the standard site. The upper back is an alternative when multiple allergy tests are placed simultaneously.

Equipment: 26–27 gauge needle, 3/8–5/8 inch length, tuberculin (1 mL) syringe.

Step by step:

1. Select the inner forearm, 2–4 finger-widths below the antecubital crease. Avoid areas with hair, moles, or broken skin.
2. Cleanse with alcohol swab. Allow to dry fully.
3. Stretch the skin taut with the non-dominant hand — pulling it taut is essential to achieve the flat surface needed for a near-horizontal insertion.
4. Hold the syringe almost parallel to the skin, bevel up, at a 10–15° angle.
5. Insert only the bevel of the needle — just far enough to place the opening within the dermis (2–3 mm).
6. Inject 0.01–0.1 mL slowly. Resistance should be felt — this is normal. A bleb will form at the injection site.
7. Withdraw the needle at the same shallow angle.
8. Do not massage. Massaging disperses the antigen and invalidates the test.
9. Circle the site with a skin marker (for allergy testing). Document time and location.

Reading the tuberculin skin test (TST / Mantoux)

The TST is the most NCLEX-tested application of the ID route. Errors in reading are among the most common clinical errors students make.

When to read: 48–72 hours after placement. Reading before 48 hours underestimates the reaction; after 72 hours, the reaction may be fading.

What to measure: Measure induration — the raised, hardened area under the skin. Use a ruler and measure the widest transverse diameter in millimeters. Erythema (redness) is not measured and is not diagnostic.

Positive thresholds by risk group:

A bleb that formed correctly during administration and then resolves within a few hours is normal and expected. The diagnostic reaction occurs over 48–72 hours as a delayed hypersensitivity response to purified protein derivative (PPD).

Site rotation and why it matters

Repeated injections at the same site cause predictable tissue damage:

Lipohypertrophy: Repeated insulin injections at the same spot stimulate fat growth beneath the skin. The resulting firm, rubbery lump is less vascular than normal tissue, so insulin injected into it absorbs erratically — causing unexplained glucose variability. Patients who have used the same insulin injection spot for years often have lipohypertrophy and do not realize it. The correction is simple: move to a fresh area of skin.

Fibrosis: Repeated IM injections at the same site can cause scar tissue formation, reducing absorption and increasing discomfort over time.

Bruising and hematoma: Injecting into a bruised site has higher risk of hematoma formation and altered drug absorption.

Rotation protocol for insulin:

1. Choose one anatomical region (most commonly the abdomen).
2. Create a systematic rotation pattern within that region — for example, moving in a clockwise pattern around the abdomen.
3. Allow at least 1 inch between injection sites.
4. Avoid the navel zone (2 inches surrounding).
5. Inspect for lipohypertrophy at each visit and redirect away from affected areas.

For full insulin site management, see insulin administration for nursing students.

Needlestick prevention and sharps safety

Needlestick injuries are a real occupational hazard. The practices below are based on OSHA bloodborne pathogen standards and CDC recommendations.

One-hand scoop technique: When recapping a needle is unavoidable (rare in clinical settings — use sharps containers instead), place the cap on a flat surface and scoop it onto the needle using only one hand. Never bring the second hand toward the uncapped needle. This is the only acceptable recapping method when recapping is necessary.

Safety-engineered needles: Use needles with built-in safety devices — retractable needles, shielded needles, or needleless systems wherever possible. Activate the safety mechanism immediately after withdrawal, before moving away from the patient.

Sharps container disposal:

• Dispose of needles and syringes immediately after use — do not recap, bend, or break needles.
• Use sharps containers that are puncture-resistant, leak-proof on all sides, and closeable.
• Never fill a sharps container past the fill line (typically 3/4 full).
• Never reach into a sharps container.

If a needlestick occurs:

1. Immediately wash the area thoroughly with soap and water.
2. Report the exposure to occupational health per facility protocol.
3. Baseline bloodwork and post-exposure prophylaxis (PEP) evaluation must happen within hours for HIV exposure — not the next day.

Proper medication handling and safe injection practices are part of the broader framework covered in safe medication administration. For sterile technique during injection preparation, see sterile technique nursing.

NCLEX tips for injection techniques

Injection technique questions appear frequently across all NCLEX domains — Pharmacological Therapies, Safety and Infection Control, and Reduction of Risk Potential. These tips address the highest-yield and most commonly missed points.

1. Ventrogluteal is the preferred IM site for adults. If the question asks which site is safest or has the fewest complications for an adult IM injection, ventrogluteal is the answer in most evidence-based scenarios.

2. Deltoid volume limit is ≤1 mL. A question may describe giving 2.5 mL to the deltoid — that is always wrong. The deltoid muscle cannot safely accommodate large volumes.

3. Dorsogluteal is high-risk. Questions about the dorsogluteal site typically test your knowledge of the sciatic nerve. Injury to the sciatic nerve causes foot drop. The site is identified by the upper outer quadrant of the buttock.

4. Aspiration is no longer required at deltoid or ventrogluteal sites. Per CDC/ACIP guidance, these sites lack large vessels. However, if an NCLEX question specifies “traditional technique” or uses older phrasing, aspiration may be the expected answer — read the question context.

5. 90° angle for IM injections. This is the standard angle. There is no IM site that uses a 45° angle.

6. Z-track is required for iron dextran. The NCLEX will ask about iron dextran administration. Always select Z-track, do not massage, and select the ventrogluteal site. Iron causes skin staining and tissue necrosis if it leaks into subcutaneous tissue.

7. Do not massage after heparin. Massaging a subcutaneous heparin injection causes hematoma and bruising. A question showing a nurse massaging after SQ heparin is showing a clinical error.

8. Do not expel the air bubble from enoxaparin prefilled syringes. The bubble is intentional and seals the drug in the subcutaneous tissue. Expelling it before injection is a clinical error.

9. Measure induration, not erythema, for the TST. This is one of the most commonly tested injection-related errors. Redness does not count. The firm, raised, palpable area (induration) is measured in millimeters.

10. TST is read at 48–72 hours. Reading at 24 hours is too early. Reading at 96 hours is too late — the reaction may have faded.

11. ≥5 mm is positive in HIV-positive patients. The positive threshold varies by risk group. Immunocompromised patients and those with recent TB contact have the lowest threshold (5 mm). Low-risk individuals require 15 mm.

12. A bleb confirms correct ID placement. If no bleb forms during an intradermal injection, the needle went subcutaneous. The test is invalid and must be repeated at a different site.

13. ID angle is 10–15°. Almost parallel to the skin, bevel up. Students often confuse this with SQ (45°). The flat, near-horizontal angle is unique to ID injections.

14. SQ volume limit is ≤1 mL. Exceeding this causes tissue damage and erratic absorption. IM volume limits are higher (site-dependent).

15. Vastus lateralis is preferred for infants. The gluteal muscles are underdeveloped until the child has been walking for approximately one year. Infants receive IM injections in the vastus lateralis.

16. Rotate insulin sites within one region. Switching randomly between the abdomen, thigh, and arm causes unpredictable glucose levels. Systematic rotation within a single region (usually the abdomen) is the correct answer for insulin injection management.

17. Do not massage intradermal injection sites. Massaging after TST placement disperses the PPD and produces an inaccurate (falsely low) reading.

18. Needle gauge and route relationship: Smaller gauge number = larger diameter needle. Thicker medications (viscous solutions, oily depots) require lower gauge numbers (larger needles) to inject. Insulin uses very fine needles (28–31 G). IM typically uses 22–25 G.

19. Longer needles for higher BMI. A 1 inch needle in a patient with a BMI of 38 may not reach the muscle — the subcutaneous fat layer is too thick. Select 1.5 inch for BMI 30–40 and consider 2 inch for BMI over 40, particularly at the ventrogluteal site.

20. Never use both hands to recap. Single-hand scoop is the only acceptable recapping method when recapping is necessary. Two-hand recapping violates OSHA standards and is the mechanism for most needlestick injuries.

21. Hold 10 seconds after injecting with Z-track. This allows the medication to disperse within the muscle before withdrawing. Withdrawing immediately may cause the drug to track back along the needle path.

22. Drug classifications affect injection route. Some drugs are only formulated for one route — hydroxyzine (Vistaril) can only be given IM (never IV — causes tissue necrosis). Understanding drug classifications helps select the correct route.

Common NCLEX injection scenarios

Connecting injection safety to broader medication practice

Injection technique does not exist in isolation. Every injection begins with accurate medication calculation to ensure the correct dose is drawn up. It occurs within the framework of the five rights of medication administration and demands full compliance with safe medication administration principles.

For procedures that require a sterile field — such as preparing a medication from a multi-dose vial under strict aseptic conditions — the protocols in sterile technique for nursing students apply directly. And when an injection is being given through a peripheral IV line rather than directly into tissue, the IV insertion and care guidelines govern site selection and maintenance.

Understanding how medications move through the body — and why different routes produce different onset, peak, and duration profiles — connects directly to drug classifications and pharmacokinetics.

Injection technique is a skill where precision matters. The right site, right angle, right volume, and right aftercare are not optional — they determine whether the medication works as intended and whether the patient stays safe. Get the fundamentals right first, practice landmark identification until it is automatic, and let the clinical rationale guide every decision at the bedside.